Does levofloxacin result in better outcomes than other antibiotics in treatment of COPD exacerbations?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does levofloxacin result in better outcomes than other antibiotics in treatment of COPD exacerbations?

Published:2020-04-21 Issue:3 Volume:24 Page:42-43
ISSN:1095-4120
Container-title:Evidence-Based Practice
language:en
Short-container-title:EBPR

Author:

Breen James,Cáceres Christie,Pizzutto Tatianna,Spradling Tyler,Wong Renee

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Fundamentals and skills

Reference4 articles.

1. Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease;Yoon;Int J Chron Obstruct Pulmon Dis.,2013

2. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval;Petitpretz;Int J Antimicrob Agents,2007

3. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease;Ruiz-González;Respirology,2007

4. Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval;Lode;Eur Respir J,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP